Day: December 26, 2023

Teleflex to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Written by Customer Service on . Posted in Public Companies.

WAYNE, Pa., Dec. 26, 2023 (GLOBE NEWSWIRE) — Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 42nd Annual J.P. Morgan Healthcare Conference at The Westin St. Francis in San Francisco, California, on Tuesday, January 9, 2024, at 3:00 p.m. (PT). A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor section of the Teleflex website at teleflex.com. About Teleflex IncorporatedTeleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access,...

Continue reading

Fusion Acquisition Corp. II Announces Redemption of Shares

Written by Customer Service on . Posted in Public Companies.

NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) — Fusion Acquisition Corp. II today announced that its board of directors (the “Board”) has determined to redeem all of its outstanding shares of Class A common stock (the “Public Shares”), effective as of December 28, 2023, because the Company will not consummate an initial business combination within the time period required by its amended and restated certificate of incorporation. As of the close of business on December 28, 2023, the Public Shares will be deemed cancelled and will represent only the rights to receive the per-share redemption price of approximately $10.67 (after taking into account the removal of a portion of the accrued interest in the trust account to pay taxes and $100,000 for dissolution expenses). In order to provide for the disbursement of funds from the trust account,...

Continue reading

AirNet Technology Inc. Announces Unaudited Financial Results for the First Half of 2023

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

BEIJING, Dec. 26, 2023 (GLOBE NEWSWIRE) — AirNet Technology Inc., formerly known as AirMedia Group Inc. (“AirNet” or the “Company”) (Nasdaq: ANTE), today announced its unaudited financial results for the first half of 2023. AIRNET TECHNOLOGY INC. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (In U.S. dollars in thousands, except share and per share data)     As of December 31,   As of June 30,       2022   2023           (Unaudited)   Assets               Current assets:               Cash and cash equivalents   $ 2,700   $ 132   Accounts receivable, net     1,421     552   Other current assets, net     65,072     28,527   Amount due from related parties     601     199   Total current assets     69,794     29,410   Property and equipment, net     10,885     10,447   Long-term investments, net     34,083     30,654   Long-term...

Continue reading

Nanobiotix Partner LianBio Assigns Its Development and Commercialization Rights for NBTXR3 in China and Other Asian Markets

Written by Customer Service on . Posted in Public Companies.

PARIS and CAMBRIDGE, Mass., Dec. 26, 2023 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that partner LianBio has entered into an agreement with Janssen Pharmaceutica NV (“Janssen”), a Johnson & Johnson company, whereby LianBio has assigned to Janssen LianBio’s exclusive rights to develop and commercialize potential first-in-class radioenhancer NBTXR3 in China, South Korea, Singapore, and Thailand. “Our collaboration strategy for the development and commercialization of NBTXR3 is rooted in a shared commitment to delivering the potential first-in-class radioenhancer to millions of patients around the world,” said Laurent Levy, Nanobiotix...

Continue reading

LianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian Markets

Written by Customer Service on . Posted in Public Companies.

SHANGHAI, China and PRINCETON, N.J., Dec. 26, 2023 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that the company has entered into an agreement with Janssen Pharmaceutica NV (“Janssen”), a Johnson & Johnson company, whereby Lian has assigned to Janssen LianBio’s exclusive rights to develop and commercialize NBTXR3, an investigational, potential first-in-class radioenhancer, in China, South Korea, Singapore and Thailand. Under the terms of the agreement, LianBio will receive a one-time payment of $25 million. In addition, LianBio is eligible to receive a sales milestone payment of $5 million. Following the deal close, LianBio will support the transition of the asset to Janssen for a period no longer...

Continue reading

Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases

Written by Customer Service on . Posted in Mergers And Acquisitions.

Proposed acquisition will enrich the AstraZeneca cell therapy pipeline with clinical-stage autologous BCMA/CD19 CAR-T therapy targeting haematologic malignancies and autoimmune diseases, and proprietary cell therapy manufacturing platform Gracell shareholders to receive $2.00 per ordinary share (equivalent to $10.00 per American Depositary Share (ADS)) in cash at closing, plus a non-tradable contingent value right (CVR) for up to $0.30 per ordinary share (equivalent to $1.50 per ADS), representing a total transaction value of up to $1.2 billion including the CVR SAN DIEGO and SUZHOU, China and SHANGHAI, China, Dec. 26, 2023 (GLOBE NEWSWIRE) — Gracell Biotechnologies Inc. (“Gracell” or the “Company”, NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing innovative cell therapies for the treatment...

Continue reading

Yihu International Blockchain Technology Co., Ltd. (BVI), a subsidiary of TGGI, and China Energy Australia Bank Capital (Hong Kong) Co., Ltd. officially signed a strategic cooperation agreement.

Written by Customer Service on . Posted in Public Companies.

China Shenzhen, Dec. 25, 2023 (GLOBE NEWSWIRE) — (Sina News Agency) On December 20, 2023, Wing Tiger International Block Chain Technology Co., Ltd., the holding company of American Global Group (stock code: TGGI), and China Energy Aoyin Capital (Hong Kong) Co., Ltd. officially signed a cooperation agreement on artificial intelligence technology and blockchain technology. The strategic cooperation agreement on R&D and operations confirms the in-depth cooperative relationship of mutual trust between the two parties. The main content of this strategic cooperation is: Wing Tiger International Block Chain Technology Co., Ltd will officially become the global operator of the artificial intelligence products (Lianxin APP, Shuan quantum encryption software and hardware) of Zhongneng Aoyin Capital (Hong Kong) Company suppliers and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.